SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : BEAT UP, NEGLECTED, UNKNOWN OR UNLOVED MICROS.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rrufff who wrote (616)6/26/2007 2:30:40 PM
From: rrufff  Read Replies (1) of 624
 
AEMD .70 + .03 see prior posts.

Aethlon Medical Signs Cooperative Research and Development Agreement with The U.S. Army Medical Research Institute of Infectious DiseasesLast update: 6/26/2007 8:30:35 AMSAN DIEGO, Jun 26, 2007 (BUSINESS WIRE)

-- Aethlon Medical, Inc. (AEMD), announced today that it has executed a Cooperative Research and Development Agreement (CRADA) with The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The focus of the agreement is to explore the therapeutic efficacy of the Aethlon Hemopurifier(R) against viral hemorrhagic fever (VHF) targets, including, but not limited to Ebola Virus, Marburg Virus, Lassa Virus, and Machupo Virus.

(see rest of pr and disclaimer)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News